Oliver Lagore Vanvalin Investment Group Invitae Corp Transaction History
Oliver Lagore Vanvalin Investment Group
- $334 Million
- Q1 2024
Shares
1 transactions
Others Institutions Holding NVTA
# of Institutions
56Shares Held
7.66MCall Options Held
0Put Options Held
0-
State Of Wyoming Cheyenne, WY3.65MShares$00.01% of portfolio
-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Goldman Sachs Group Inc New York, NY902KShares$00.0% of portfolio
-
Green Alpha Advisors, LLC450KShares$00.0% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...